BRIEF published on 05/05/2026 at 02:39, 4 months 6 days ago Dexus Finance Releases March 2026 Quarter Update Investor Relations Financial Reporting Dexus Finance Quarterly Update Macquarie Conference
BRIEF published on 05/05/2026 at 02:39, 4 months 6 days ago Dexus Finance publie sa mise à jour du trimestre de mars 2026 Information Financière Relations Avec Les Investisseurs Dexus Finance Mise À Jour Trimestrielle Conférence Macquarie
BRIEF published on 05/05/2026 at 02:04, 4 months 6 days ago Barton Gold Unveils High-Grade Silver Results at Tolmer Drilling Program High-grade Concentrate Tolmer Silver Metallurgical Evaluation Gravity Process
BRIEF published on 05/05/2026 at 02:04, 4 months 6 days ago Barton Gold dévoile des résultats exceptionnels pour l'argent de haute qualité à Tolmer Programme De Forage Tolmer Silver Concentré De Haute Qualité Évaluation Métallurgique Processus De Gravité
BRIEF published on 05/05/2026 at 00:00, 4 months 6 days ago Avant Brands Reports Voting Outcomes from 2026 Annual Meeting Cannabis Industry Director Election Avant Brands Auditor Re-appointment 2026 Shareholder Meeting
BRIEF published on 05/05/2026 at 00:00, 4 months 6 days ago Avant Brands publie les résultats des votes de son assemblée générale annuelle de 2026. Avant Brands Élection Du Directeur L'industrie Du Cannabis Assemblée Générale Des Actionnaires De 2026 Renouvellement Du Mandat De L'auditeur
BRIEF published on 05/04/2026 at 23:34, 4 months 6 days ago Nanobiotix modifie le protocole de son étude de phase 3 sur le cancer FDA NANOBIOTIX Protocole Modifié NANORAY-312 Cancer Tête Et Cou
BRIEF published on 05/04/2026 at 23:34, 4 months 6 days ago Nanobiotix Updates Protocol for Phase 3 Cancer Study FDA Approval Protocol Amendment Phase 3 Study NANOBIOTIX JNJ-1900
BRIEF published on 05/04/2026 at 23:34, 4 months 6 days ago Nanobiotix met à jour le protocole de son étude de phase 3 sur le cancer Approbation De La FDA Étude De Phase 3 NANOBIOTIX JNJ-1900 Amendement Au Protocole
BRIEF published on 05/04/2026 at 23:34, 4 months 6 days ago Nanobiotix modifies the protocol of its phase 3 cancer study FDA Head And Neck Cancer NANOBIOTIX NANORAY-312 Modified Protocol
Published on 09/11/2026 at 17:00, 1 hour 29 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 1 hour 29 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 3 hours 4 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 3 hours 29 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 3 hours 59 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 14 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 29 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 29 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 11 hours 29 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 11 hours 29 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 11 hours 29 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 11 hours 29 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 22 hours 59 minutes ago Availability of the 2026 Interim Financial Report
